Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 36 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE FERMEUSE-BRISMEE from Charleroi, company number BE0744713936, closed financial year 2025 with a result of € 2,438 after tax. For that financial year PHARMACIE FERMEUSE-BRISMEE recorded a gross margin of € 220,873 and equity of € -21,456. Compared with financial year 2024, the result moved from € -5,648 to € 2,438. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 7, 2026.
€ -21,456
▼ € 562 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2,438
▲ still € 5,648 loss in 2024
Profit after tax over the fiscal year.
€ 175,826
▲ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 3,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
2.5
▼ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 96,398
▼ 6% vs 2024
€ 38,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 36,465
▼ 41% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 238,795
▼ 18% vs 2024
€ 54,117 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 49,900
▼ 14% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 33,960
▲ 18% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 203,247 | € 220,513 | € 214,790 | € 220,873 | ▲ 3% |
| Profit after taxes | € 212 | € 5,412 | € -5,648 | € 2,438 | ▲ € 8,086 |
| Equity | € -14,657 | € -15,245 | € -20,893 | € -21,456 | ▼ € 562 |
| Total debts | € 1,127,907 | € 1,044,163 | € 981,169 | € 891,131 | ▼ 9% |
| Cash | € 223,456 | € 258,060 | € 171,674 | € 175,826 | ▲ 2% |
| Land & buildings | € 197,207 | € 159,782 | € 147,412 | € 130,387 | ▼ 12% |
| Retained profit | € -34,657 | € -35,245 | € -40,893 | € -41,456 | ▼ € 562 |
| Dividend | € 8,000 | € 6,000 | € 0 | € 3,000 | |
| Bank debt | € 374,344 | € 300,371 | € 292,107 | € 238,795 | ▼ 18% |
| Balance sheet total | € 1,113,251 | € 1,028,917 | € 960,276 | € 869,675 | ▼ 9% |
| Employees (FTE) | 2.2 | 2.4 | 2.8 | 2.5 | ▼ 0.3 |
By gross margin, PHARMACIE FERMEUSE-BRISMEE ranks 224th of 478 companies with main activity “Detailhandel in farmaceutische producten” in Hainaut that publish figures (fiscal year 2025).
Key figures of PHARMACIE FERMEUSE-BRISMEE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2026 has not been filed yet; it was expected before 31 October 2026.
Ask about PHARMACIE FERMEUSE-BRISMEE the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMACIE FERMEUSE-BRISMEE?
What happened at PHARMACIE FERMEUSE-BRISMEE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 2,438. filed late Source: NBB ↗
- SALOME BRICHART became a director. NBB
- CHRISTINE FERMEUSE stepped down as director. NBB
- New establishment in Charleroi. KBO
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
- CHRISTELLE BRISMEE became a director. NBB
- CHRISTINE FERMEUSE became a director. NBB
In short
From € 212 profit in 2022 to € 2,438 profit in 2025.
Paid € 70,718 in corporate taxes since 2022.
Best year ever: 2023, with € 5,412 profit.
On average € 88,300 of value added per employee in 2025.
Management
Behind PHARMACIE FERMEUSE-BRISMEE are SALOME BRICHART and CHRISTELLE BRISMEE.
Directors
According to the 2025 annual accounts
SALOME BRICHART
Director
since 2024
CHRISTELLE BRISMEE
Administrator-manager
since 2020
CHRISTINE FERMEUSE
Administrator-manager
since 2020 · until 2024
Establishments
Establishment units
Physical locations of this company
Rue Albert Camus 72-74
6031 Charleroi
Rue des Barbieux 60
6031 Charleroi
Active since 4 March 2020
Rue Albert Camus 74
6031 Charleroi
Active since 4 March 2020
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Hainaut
Same main activity (Detailhandel in farmaceutische producten), 514 active companies in Hainaut, largest first.
€ 51.5 million revenue · 2025 · Frameries
€ 3.9 million gross margin · 2025 · Enghien
LES PHARMACIES BENIT-DEHAUT-RION
€ 1.9 million gross margin · 2025 · Dour
€ 1.9 million gross margin · 2025 · Antoing
€ 1.5 million gross margin · 2025 · Celles (lez-Tournai)
€ 1.4 million gross margin · 2025 · Silly
Details
- Company number
- 0744.713.936
- VAT number
- BE 0744.713.936
- Registered office
- Rue Albert Camus 72-74, 6031 Charleroi
- Names & denominations
- PHARMACIE FERMEUSE-BRISMEE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 March 2020
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten